Digital assay of circulating tumor cells may improve diagnos
Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyze circulating tumor cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, increasing the likelihood of successful treatment. In their report published in PNAS, a team from the Massachusetts General Hospital (MGH) Cancer Center describe how combining use of the MGH-developed CTC-iChip with RNA-based digital PCR greatly improved detection of cancer cells in the blood of patients with hepatocellular carcinoma (HCC), the most common type of liver cancer.

Read more at: https://medicalxpress.com/news/2017-01-digital-assay-circulating-tumor-cells.html#jCp
Like
Comment
Share